344 related articles for article (PubMed ID: 11002280)
1. Hyphenated HPLC-NMR and its applications in drug discovery.
Peng SX
Biomed Chromatogr; 2000 Oct; 14(6):430-41. PubMed ID: 11002280
[TBL] [Abstract][Full Text] [Related]
2. The potential of LC-NMR in phytochemical analysis.
Wolfender JL; Ndjoko K; Hostettmann K
Phytochem Anal; 2001; 12(1):2-22. PubMed ID: 11704957
[TBL] [Abstract][Full Text] [Related]
3. HPLC-SPE-NMR in pharmaceutical development: capabilities and applications.
Sandvoss M; Bardsley B; Beck TL; Lee-Smith E; North SE; Moore PJ; Edwards AJ; Smith RJ
Magn Reson Chem; 2005 Sep; 43(9):762-70. PubMed ID: 16049946
[TBL] [Abstract][Full Text] [Related]
4. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of degradation products of dicloxacillin in bulk drug and pharmaceutical dosage forms.
Raj TJ; Bharati CH; Rao KR; Rao PS; Narayan GK; Parikh K
J Pharm Biomed Anal; 2007 Mar; 43(4):1470-5. PubMed ID: 17125952
[TBL] [Abstract][Full Text] [Related]
6. LC-SPE-NMR-MS: a total analysis system for bioanalysis.
Schlotterbeck G; Ceccarelli SM
Bioanalysis; 2009 Jun; 1(3):549-59. PubMed ID: 21083152
[TBL] [Abstract][Full Text] [Related]
7. Application of high-performance liquid chromatography hyphenated techniques for identification of degradation products of cefpodoxime proxetil.
Fukutsu N; Kawasaki T; Saito K; Nakazawa H
J Chromatogr A; 2006 Oct; 1129(2):153-9. PubMed ID: 16846608
[TBL] [Abstract][Full Text] [Related]
8. NMR spectroscopy as a tool to close the gap on metabolite characterization under MIST.
Caceres-Cortes J; Reily MD
Bioanalysis; 2010 Jul; 2(7):1263-76. PubMed ID: 21083239
[TBL] [Abstract][Full Text] [Related]
9. Metabolite identification via LC-SPE-NMR-MS of the in vitro biooxidation products of a lead mGlu5 allosteric antagonist and impact on the improvement of metabolic stability in the series.
Ceccarelli SM; Schlotterbeck G; Boissin P; Binder M; Buettelmann B; Hanlon S; Jaeschke G; Kolczewski S; Kupfer E; Peters JU; Porter RH; Prinssen EP; Rueher M; Ruf I; Spooren W; Stämpfli A; Vieira E
ChemMedChem; 2008 Jan; 3(1):136-44. PubMed ID: 17994660
[TBL] [Abstract][Full Text] [Related]
10. High-performance liquid chromatography/NMR spectrometry/mass spectrometry: further advances in hyphenated technology.
Holt RM; Newman MJ; Pullen FS; Richards DS; Swanson AG
J Mass Spectrom; 1997 Jan; 32(1):64-70. PubMed ID: 9008869
[TBL] [Abstract][Full Text] [Related]
11. Analytical strategies for identifying drug metabolites.
Prakash C; Shaffer CL; Nedderman A
Mass Spectrom Rev; 2007; 26(3):340-69. PubMed ID: 17405144
[TBL] [Abstract][Full Text] [Related]
12. Hyphenated NMR methods in natural products research, Part 2: HPLC-SPE-NMR and other new trends in NMR hyphenation.
Jaroszewski JW
Planta Med; 2005 Sep; 71(9):795-802. PubMed ID: 16206031
[TBL] [Abstract][Full Text] [Related]
13. Important roles of the hyphenated HPLC-DAD-MS-SPE-NMR technique in metabonomics.
Tang H; Xiao C; Wang Y
Magn Reson Chem; 2009 Dec; 47 Suppl 1():S157-62. PubMed ID: 19757407
[TBL] [Abstract][Full Text] [Related]
14. Online hyphenated liquid chromatography-nuclear magnetic resonance spectroscopy-mass spectrometry for drug metabolite and nature product analysis.
Yang Z
J Pharm Biomed Anal; 2006 Feb; 40(3):516-27. PubMed ID: 16280226
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of degradation products of citalopram and process-related impurities using RP-HPLC.
Rao RN; Raju AN; Narsimha R
J Sep Sci; 2008 Jun; 31(10):1729-38. PubMed ID: 18481321
[TBL] [Abstract][Full Text] [Related]
16. Drug-excipient compatibility testing-Identification and characterization of degradation products of phenylephrine in several pharmaceutical formulations against the common cold.
Douša M; Gibala P; Havlíček J; Plaček L; Tkadlecová M; Břicháč J
J Pharm Biomed Anal; 2011 Jul; 55(5):949-56. PubMed ID: 21481557
[TBL] [Abstract][Full Text] [Related]
17. Major degradation product identified in several pharmaceutical formulations against the common cold.
Marín A; Espada A; Vidal P; Barbas C
Anal Chem; 2005 Jan; 77(2):471-7. PubMed ID: 15649042
[TBL] [Abstract][Full Text] [Related]
18. Use of (1)H NMR to facilitate solubility measurement for drug discovery compounds.
Lin M; Tesconi M; Tischler M
Int J Pharm; 2009 Mar; 369(1-2):47-52. PubMed ID: 19073245
[TBL] [Abstract][Full Text] [Related]
19. Structural identification and characterization of potential degradants of zotarolimus on zotarolimus-coated drug-eluting stents.
Chen Q; Zielinski D; Chen J; Nowak S; Zhou CC
J Pharm Biomed Anal; 2009 Dec; 50(5):778-86. PubMed ID: 19581067
[TBL] [Abstract][Full Text] [Related]
20. Rapid structure elucidation of drug degradation products using mechanism-based stress studies in conjunction with LC-MS(n) and NMR spectroscopy: identification of a photodegradation product of betamethasone dipropionate.
Lin M; Li M; Buevich AV; Osterman R; Rustum AM
J Pharm Biomed Anal; 2009 Oct; 50(3):275-80. PubMed ID: 19525081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
